POLYDEX-N
Sterile
Eye drops

Description:
The ophthalmic
preparation of Polydex-N combines
two antibiotics, Neomycin Sulphate and Polymyxin B Sulphate, offering broad-spectrum
antibacterial activity with the anti-inflammatory activity
of corticosteroid, dexamethasone,
for combating certain microbial infections of the anterior
segment of the eye(s). The eye drop is formulated in an isotonic
menstrum containing hydroxypropyl methylcellulose for maximum effectiveness
and comfort.
Composition:
Each ml of solution
contains Dexamethasone 0.1%, Neomycin Sulphate 3,500 I.U./ml, Polymyxin B Sulphate
6,000 I.U./ml.
Clinical Pharmacology:
Corticosteroids
suppress the inflammatory response to a variety of agents
and they probably delay or slow healing. Since corticosteroids
may inhibit the body’s defense mechanism against infection,
a concomitant antimicrobial drug may be used when this inhibition
is considered to be clinically significant in a particular
case. The anti-infective component in the combination is included
to provide action against specific organisms susceptible to
it. Neomycin Sulphate is considered active against the following
microorganisms: Staphylococcus aureus, Corynebacterium diphtheriae, Streptococcus Viridans, Escherichia coli,Klebsiella pneumoniae,Proteus vulgaris, Aerobacter aerogenes,
and Haemophilus influenzae.Polymyxin B Sulphate
is considered active against the following microorganism:
Pseudomonas aeruginosa, Aerobacter aerogenes,
Escherichia coli, Klebsiella pneumoniae and Koch-Weeks bacillus.
When a decision
to administer both a corticosteroids and an antimicrobial
is made, the administration of such drugs in combination has
the advantage of greater patient compliance and convenience,
with the added assurance that the appropriate dosage of both
drugs is administered, plus assured compatibility of ingredients
when both types of drugs are in the same formulation and,
particularly, that the correct volume of drug is delivered
and retained.
The relative
potency of corticosteroids depends on the molecular structure,
concentration and release from the vehicle.
Indications:
Polydex-N is indicated in ocular
inflammation when concurrent use of an antimicrobial is judged
necessary.
Dosage & Administration:
One or two drops
topically into the conjunctival sac(s). In severe disease,
drops may be used hourly, being tapered to discontinuation
as the inflammation subsides. In mild disease, drops may be
used up to four to six times daily.
Adverse Reactions:
Adverse reactions have occurred with steroid/anti-infective
combination drugs which can be attributed to the steroid component,
the anti-infective component, or the combination. Exact incidence
figures are not available since no denominator of treated
patients is available. Reactions occurring most often from
the presence of the anti-infective ingredient are allergic
sensitizations. The reactions due to the steroid component
in decreasing order of frequency are: elevation of intraocular
pressure (IOP) with possible development of glaucoma, and
infrequent optic nerve damage, posterior sub-capsular cataract
formation and delayed wound healing.
Contraindications:
Epithelial herpes
simplex keratitis (dentritic keratitis),
vaccinia, varicella, and many other viral diseases of the
cornea and conjunctiva. Mycobacterial
infection of the eye. Fungal diseases of ocular structures.
Hypersensitivity to a component of the medication (Hypersensitivity
to the antibiotic component occurs at a higher rate than for
other components).
The use of these
combinations is always contraindicated after uncomplicated
removal of a corneal foreign body.
Warnings/Precautions:
Prolonged use
may result in glaucoma, with damage to the optic nerve, defects
in visual acuity and fields of vision, and posterior subcapsular
cataract formation. Prolonged use may suppress the host response
and thus increase the hazard of secondary ocular infections.
In those diseases causing thinning of the cornea or sclera,
perforations have been known to occur with the use of topical
steroids. In acute purulent conditions of the eye, steroids
may mask infection or enhance existing infection. If these
products are used for 10 days or longer, intraocular pressure
should be routinely monitored even though it may be difficult
in children and uncooperative patients.
Employment of
steroid medication in the treatment of herpes simplex requires
great caution. The possibility of persistent fungal infections
of the cornea should be considered after prolonged steroid
dosing.
Additional information:
Close the bottle
immediately after use.
Do not use more
than one month after first opening.
Packing:
Dropper bottle
of 5 ml.